Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
The Global Research Awards for Nicotine Dependence (GRAND) Program is a relatively new initiative from Pfizer. The inaugural funding took place in 2008. They are a program of research grants funded by Pfizer to support basic and clinical research into the mechanisms of tobacco and nicotine dependence with an upper limit of US$150,000.
